Evidence map›Paper›PMID 32514053›Full record

ArticleScientific reports2020

The impact of capsaicinoids on APP processing in Alzheimer's disease in SH-SY5Y cells.

Marcus O W Grimm, Tamara Blümel, Anna A Lauer, Daniel Janitschke, Christoph Stahlmann, Janine Mett, Viola J Haupenthal, Anna-Maria Miederer, Barbara A Niemeyer, Heike S Grimm and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. A Systematic Review of the Effects of Capsaicin on Alzheimer's Disease.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. TRPV1 Modulator Ameliorates Alzheimer-Like Amyloid-Oxidative medicine and cellular longevity · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Marcus O W Grimm *Experimental Neurology, Saarland University, Homburg, Saar, Germany. marcus.grimm@mx.uni-saarland.de.
Tamara Blümel *Experimental Neurology, Saarland University, Homburg, Saar, Germany.
Anna A LauerExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Daniel JanitschkeExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Christoph StahlmannExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Janine MettExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Viola J HaupenthalExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Anna-Maria MiedererMolecular Biophysics, CIPMM, Saarland University, Homburg, Saar, Germany.
Barbara A NiemeyerMolecular Biophysics, CIPMM, Saarland University, Homburg, Saar, Germany.
Heike S GrimmExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Tobias HartmannExperimental Neurology, Saarland University, Homburg, Saar, Germany.
Saarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vanilloid capsaicin is a widely consumed spice, known for its burning and "hot" sensation through activation of TRPV1 ion-channels, but also known to decrease oxidative stress, inflammation and influence tau-pathology. Beside these positive effects, little is known about its effects on amyloid-precursor-protein (APP) processing leading to amyloid-β (Aβ), the major component of senile plaques. Treatment of neuroblastoma cells with capsaicinoids (24 hours, 10 µM) resulted in enhanced Aβ-production and reduced Aβ-degradation, leading to increased Aβ-levels. In detailed analysis of the amyloidogenic-pathway, both BACE1 gene-expression as well as protein-levels were found to be elevated, leading to increased β-secretase-activity. Additionally, γ-secretase gene-expression as well as activity was enhanced, accompanied by a shift of presenilin from non-raft to raft membrane-domains where amyloidogenic processing takes place. Furthermore, impaired Aβ-degradation in presence of capsaicinoids is dependent on the insulin-degrading-enzyme, one of the major Aβ-degrading-enzymes. Regarding Aβ-homeostasis, no differences were found between the major capsaicinoids, capsaicin and dihydrocapsaicin, and a mixture of naturally derived capsaicinoids; effects on Ca

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesCapsaicinCell Line, TumorContraindications, DrugGene ExpressionHumansNeuroblastomaAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBACE1 protein, humanCapsaicin

Identifiers

PMID32514053
PMCPMC7280252
OpenAlexW3033630631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.